Investor insights
Sectors invested in
Pain Management and Women's Health1
Pharmaceutical1
Health Care1
Biotechnology1
Funding rounds participated in
$88M sweet spot round size
Most of their 1 investments are in rounds between $88M and $88M
Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Pharmaceutical
Clinical Trials
Date founded
2007
Investments made
X
Xanodyne Pharmaceuticals, Inc. raised $88M on October 30, 2009
Investors: Aisling Capital, Longitude Capital, Silver Point Capital, HealthCare Ventures LLC, MPM Capital, Blue Chip Venture Company and Union Spring Pharmaceuticals
Funding rounds raised
Total raised
$5M
from 1 investors over 1 rounds
U
Union Spring Pharmaceuticals raised $5M on October 20, 2009
Investors: Blue Chip Venture Company